Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Influenza B virus"" wg kryterium: Temat


Tytuł :
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.
Autorzy :
Melidou A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Pereyaslov D; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Hungnes O; Norwegian Institute of Public Health, Oslo, Norway.
Prosenc K; Laboratory for Public Health Virology, National Influenza Centre Slovenia, National Laboratory for Health, Environment and Food, Ljubljana, Slovenia.
Alm E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Adlhoch C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Fielding J; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Sneiderman M; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Martinuka O; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Celentano LP; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Pebody R; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Pokaż więcej
Corporate Authors :
WHO European Region influenza surveillance network; The members of the network are listed below.
WHO European Region Influenza Surveillance Network author list
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2020 Nov; Vol. 25 (46).
Typ publikacji :
Journal Article
MeSH Terms :
Epidemiological Monitoring*
Coronavirus Infections/*epidemiology
Disease Notification/*statistics & numerical data
Influenza A virus/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Influenza, Human/*virology
Antigens, Viral/genetics ; Betacoronavirus ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Influenza A virus/genetics ; Influenza B virus/genetics ; Pandemics ; Pneumonia, Viral ; Population Surveillance ; RNA, Viral/genetics ; Sequence Analysis, DNA
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Lessons of the month: Co-infection with SARS-CoV-2 and influenza B virus in a patient with community-acquired pneumonia.
Autorzy :
Coutinho A; Princess Royal Hospital, Telford, UK .
Riaz A; Princess Royal Hospital, Telford, UK.
Makan A; Princess Royal Hospital, Telford, UK.
Crawford E; Princess Royal Hospital, Telford, UK.
Dev D; Princess Royal Hospital, Telford, UK.
Srinivasan K; Princess Royal Hospital, Telford, UK.
Ahmad N; Princess Royal Hospital, Telford, UK.
Moudgil H; Princess Royal Hospital, Telford, UK.
Pokaż więcej
Źródło :
Clinical medicine (London, England) [Clin Med (Lond)] 2020 Nov; Vol. 20 (6), pp. e262-e263.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Coinfection*
Coronavirus Infections*
Influenza B virus*
Influenza, Human*
Pandemics*
Pneumonia, Viral*
Aged ; Betacoronavirus ; Community-Acquired Infections ; Continuous Positive Airway Pressure ; Humans ; Lung/diagnostic imaging ; Lung/pathology ; Male
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Repeat Molecular Testing for Respiratory Pathogens: Diagnostic Gain or Diminishing Returns?
Autorzy :
Qavi AJ; Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO.
McMullen A; Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO.
Burnham CD; Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO.
Anderson NW; Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO.
Pokaż więcej
Źródło :
The journal of applied laboratory medicine [J Appl Lab Med] 2020 Sep 01; Vol. 5 (5), pp. 897-907.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A virus*/genetics
Influenza A virus*/isolation & purification
Influenza B virus*/genetics
Influenza B virus*/isolation & purification
Influenza, Human*/diagnosis
Influenza, Human*/virology
RNA Virus Infections*/diagnosis
RNA Virus Infections*/virology
Respiratory Tract Infections*/diagnosis
Respiratory Tract Infections*/virology
Nucleic Acid Amplification Techniques/*methods
Diagnosis, Differential ; Humans ; Multiplex Polymerase Chain Reaction/methods ; Procedures and Techniques Utilization ; Viruses/classification ; Viruses/isolation & purification
Czasopismo naukowe
Tytuł :
Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture.
Autorzy :
Plant EP; Office of Vaccine Research and Review, US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Manukyan H; Office of Vaccine Research and Review, US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Laassri M; Office of Vaccine Research and Review, US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Ye Z; Office of Vaccine Research and Review, US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 14; Vol. 15 (9), pp. e0239015. Date of Electronic Publication: 2020 Sep 14 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Antigenic Variation/*genetics
Epitopes/*genetics
Influenza B virus/*genetics
Animals ; Antibodies, Viral/blood ; Dogs ; Genome, Viral/genetics ; Genomics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Influenza B virus/growth & development ; Influenza, Human/virology ; Madin Darby Canine Kidney Cells
Czasopismo naukowe
Tytuł :
Prevalence and factors influencing the distribution of influenza viruses in Kenya: Seven-year hospital-based surveillance of influenza-like illness (2007-2013).
Autorzy :
Umuhoza T; Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Bulimo WD; Department of Emerging Infectious Diseases, United State Army Medical Research Directorate - Africa, Nairobi, Kenya.; Department of Biochemistry, School of Medicine, University of Nairobi, Nairobi, Kenya.
Oyugi J; Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Schnabel D; US President's Malaria Initiative, Freetown, Sierra Leone.
Mancuso JD; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Aug 21; Vol. 15 (8), pp. e0237857. Date of Electronic Publication: 2020 Aug 21 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Demography ; Epidemiological Monitoring ; Female ; Humans ; Infant ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Influenza, Human/virology ; Kenya/epidemiology ; Male ; Middle Aged ; Nasopharynx/virology ; Prevalence
Czasopismo naukowe
Tytuł :
Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
Autorzy :
Fang QQ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China. Electronic address: .
Huang WJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Li XY; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Cheng YH; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Tan MJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Liu J; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Wei HJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
Meng Y; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, 710054, China.
Wang DY; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China. Electronic address: .
Pokaż więcej
Źródło :
Virology [Virology] 2020 Jun; Vol. 545, pp. 1-9. Date of Electronic Publication: 2020 Feb 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Viral*
Amides/*administration & dosage
Antiviral Agents/*administration & dosage
Influenza B virus/*drug effects
Influenza, Human/*drug therapy
Oseltamivir/*administration & dosage
Pyrazines/*administration & dosage
Animals ; Female ; Humans ; Influenza B virus/genetics ; Influenza B virus/physiology ; Influenza, Human/virology ; Mice ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł :
Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013-2019.
Autorzy :
Chen L; Department of Infectious Diseases, Beijing Jishuitan Hospital, 4th Medical College of Peking University, Beijing, China. .
Han XD; Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao City, Shandong Province, China.
Li YL; Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Zhang CX; Department of Pulmonary and Critical Care Medicine, Beijing Huimin Hospital, Beijing, China.
Xing XQ; Department of Pulmonary and Critical Care Medicine, the 2nd People's Hospital of Yunnan Province, Kunming City, Yunnan Province, China.
Pokaż więcej
Źródło :
Infectious diseases of poverty [Infect Dis Poverty] 2020 Apr 22; Vol. 9 (1), pp. 42. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A virus/*physiology
Influenza B virus/*physiology
Influenza, Human/*complications
Pneumonia/*epidemiology
Adult ; Aged ; Aged, 80 and over ; China/epidemiology ; Female ; Hospitalization ; Humans ; Influenza A virus/genetics ; Influenza B virus/classification ; Influenza B virus/genetics ; Influenza B virus/isolation & purification ; Influenza, Human/epidemiology ; Influenza, Human/therapy ; Influenza, Human/virology ; Male ; Middle Aged ; Pneumonia/etiology ; Pneumonia/mortality ; Pneumonia/therapy ; Retrospective Studies ; Seasons
Czasopismo naukowe
Tytuł :
Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility.
Autorzy :
Farrukee R; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Tai CM; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Oh DY; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; School of Health and Life Sciences, Federation University, Churchill, Victoria, Australia.
Anderson DE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Gunalan V; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore.
Hibberd M; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore.
Lau GY; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Barr IG; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; School of Health and Life Sciences, Federation University, Churchill, Victoria, Australia.
Messling VV; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Veterinary Medicine Division, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
Maurer-Stroh S; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore.; National Public Health Laboratories, National Centre for Infectious Diseases, Ministry of Health, Singapore.; Department of Biological Sciences, National University Singapore, Singapore.
Hurt AC; WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2020 Jun 18; Vol. 16 (6), pp. e1008592. Date of Electronic Publication: 2020 Jun 18 (Print Publication: 2020).
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial, Veterinary; Research Support, Non-U.S. Gov't
MeSH Terms :
Orthomyxoviridae Infections*/drug therapy
Orthomyxoviridae Infections*/genetics
Orthomyxoviridae Infections*/metabolism
Orthomyxoviridae Infections*/pathology
Influenza A Virus, H1N1 Subtype/*metabolism
Influenza A Virus, H3N2 Subtype/*metabolism
Influenza B virus/*metabolism
Oseltamivir/*pharmacology
Amino Acid Substitution ; Animals ; Disease Models, Animal ; Drug Evaluation, Preclinical ; Female ; Ferrets ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Macaca fascicularis ; Macrolides ; Male ; Mutation, Missense ; Neuraminidase/genetics ; Neuraminidase/metabolism
Czasopismo naukowe
Tytuł :
The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience.
Autorzy :
Assaf-Casals A; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Saleh Z; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Khafaja S; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Fayad D; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Ezzeddine H; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Saleh M; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Chamseddine S; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Sayegh R; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Sharara SL; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Chmaisse A; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Kanj SS; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Kanafani Z; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Hanna-Wakim R; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Araj GF; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Mahfouz R; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.; Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon.
Saito R; Department of Public Health at Niigata University, Niigata, Japan.
Suzuki H; Department of Public Health at Niigata University, Niigata, Japan.
Zaraket H; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. .; Department of Experimental Pathology, Immunology & Microbiology, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. .
Dbaibo GS; Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. .; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 May 12; Vol. 20 (1), pp. 339. Date of Electronic Publication: 2020 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
Pandemics*
Coinfection/*diagnosis
Coinfection/*epidemiology
Influenza A Virus, H1N1 Subtype/*genetics
Influenza B virus/*genetics
Influenza, Human/*diagnosis
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/therapeutic use ; Child ; Child, Preschool ; Coinfection/complications ; Coinfection/drug therapy ; Female ; Hospitalization ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza B virus/immunology ; Influenza, Human/complications ; Influenza, Human/drug therapy ; Lebanon/epidemiology ; Male ; Middle Aged ; Morbidity ; Pneumonia/etiology ; Retrospective Studies ; Tertiary Care Centers ; Young Adult
Czasopismo naukowe
Tytuł :
Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells.
Autorzy :
Jiao P; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresourses & Laboratory of Animal Infectious Diseases, College of Animal Sciences and Veterinary Medicine, Guangxi University, Nanning, Guangxi, China.; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Fan W; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Cao Y; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Zhang H; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Tian L; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Sun L; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Luo T; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresourses & Laboratory of Animal Infectious Diseases, College of Animal Sciences and Veterinary Medicine, Guangxi University, Nanning, Guangxi, China.
Liu W; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresourses & Laboratory of Animal Infectious Diseases, College of Animal Sciences and Veterinary Medicine, Guangxi University, Nanning, Guangxi, China.; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.; Institute of Microbiology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China.
Li J; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Apr 08; Vol. 15 (4), pp. e0231039. Date of Electronic Publication: 2020 Apr 08 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza B virus/*metabolism
Influenza, Human/*metabolism
Interferons/*metabolism
A549 Cells/metabolism ; A549 Cells/virology ; Blotting, Western ; Fluorescent Antibody Technique ; Gene Expression Regulation, Viral ; Humans ; Influenza B virus/genetics ; Influenza, Human/virology ; Real-Time Polymerase Chain Reaction ; Viral Plaque Assay ; Virus Replication
Czasopismo naukowe
Tytuł :
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018.
Autorzy :
Price OH; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Spirason N; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Rynehart C; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Brown SK; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Todd A; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Peck H; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Patel M; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Soppe S; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Barr IG; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Chow MK; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
Pokaż więcej
Źródło :
Communicable diseases intelligence (2018) [Commun Dis Intell (2018)] 2020 Mar 16; Vol. 44. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A virus*/drug effects
Influenza A virus*/genetics
Influenza B virus*/drug effects
Influenza B virus*/genetics
Antiviral Agents/*pharmacology
Influenza Vaccines/*immunology
Influenza, Human/*prevention & control
Animals ; Antigens, Viral ; Australia/epidemiology ; Chickens ; Drug Resistance, Viral ; Humans ; Influenza Vaccines/therapeutic use ; Oseltamivir ; Phylogeny ; World Health Organization ; Zanamivir
Czasopismo naukowe
Tytuł :
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
Autorzy :
Skowronski DM; University of British Columbia, Vancouver, Canada.; British Columbia Centre for Disease Control, Vancouver, Canada.
Zou M; British Columbia Centre for Disease Control, Vancouver, Canada.
Sabaiduc S; British Columbia Centre for Disease Control, Vancouver, Canada.
Murti M; University of Toronto, Toronto, Canada.; Public Health Ontario, Toronto, Canada.
Olsha R; Public Health Ontario, Toronto, Canada.
Dickinson JA; University of Calgary, Calgary, Canada.
Gubbay JB; University of Toronto, Toronto, Canada.; Public Health Ontario, Toronto, Canada.
Croxen MA; University of Alberta, Edmonton, Canada.; Public Health Laboratory (ProvLab), Alberta Precision Laboratories, Edmonton, Alberta, Canada.
Charest H; Institut National de Santé Publique du Québec, Québec, Canada.
Jassem A; University of British Columbia, Vancouver, Canada.; British Columbia Centre for Disease Control, Vancouver, Canada.
Krajden M; University of British Columbia, Vancouver, Canada.; British Columbia Centre for Disease Control, Vancouver, Canada.
Bastien N; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Li Y; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
De Serres G; Centre Hospitalier Universitaire de Québec, Québec, Canada.; Laval University, Quebec, Canada.; Institut National de Santé Publique du Québec, Québec, Canada.
Pokaż więcej
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2020 Feb; Vol. 25 (7).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza Vaccines/*administration & dosage
Influenza, Human/*epidemiology
Influenza, Human/*prevention & control
Adolescent ; Adult ; Aged ; Antigens, Viral/analysis ; Canada/epidemiology ; Child ; Child, Preschool ; Female ; Genotype ; Hemagglutination Inhibition Tests ; Humans ; Infant ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/immunology ; Influenza B virus/genetics ; Influenza B virus/immunology ; Influenza Vaccines/immunology ; Male ; Middle Aged ; Molecular Sequence Data ; Nasopharynx/virology ; Nose/virology ; Real-Time Polymerase Chain Reaction ; Seasons ; Sentinel Surveillance ; Sequence Analysis, DNA ; Young Adult
Czasopismo naukowe
Tytuł :
Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.
Autorzy :
LeBlanc JJ; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
ElSherif M; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Mulpuru S; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Warhuus M; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Ambrose A; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Andrew M; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Boivin G; Centre Hospitalier Universitaire de Québec, QC, Canada.
Bowie W; University of British Columbia, Vancouver, BC, Canada.
Chit A; Sanofi Pasteur, Swiftwater, PA, USA.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Dos Santos G; Business & Decision Life Sciences (on behalf of GSK), Bruxelles, Belgium.; Present address: GSK, Wavre, Belgium.
Green K; Mount Sinai Hospital, Toronto, ON, Canada.
Halperin SA; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Hatchette TF; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Ibarguchi B; GSK, Mississauga, ON, Canada.; Present address: Bayer, Inc., Mississauga, Ontario, Canada.
Johnstone J; Public Health Ontario and University of Toronto, Toronto, ON, Canada.
Katz K; North York General Hospital, Toronto, ON, Canada.
Langley JM; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
Lagacé-Wiens P; St Boniface Hospital, Winnipeg, MB, Canada.
Loeb M; Public Health Ontario and University of Toronto, Toronto, ON, Canada.
Lund A; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
MacKinnon-Cameron D; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
McCarthy A; Ottawa Hospital General, Ottawa, Ontario, Canada.
McElhaney JE; Health Sciences North Research Institute, Sudbury, ON, Canada.
McGeer A; Mount Sinai Hospital, Toronto, ON, Canada.
Poirier A; Centre Intégré Universitaire de Santé et Services Sociaux, Quebec, QC, Canada.
Powis J; Toronto East General Hospital, Toronto, ON, Canada.
Richardson D; William Osler Health System, Brampton, ON, Canada.
Semret M; McGill University, Montreal, QC, Canada.
Shinde V; GSK, King of Prussia, PA, USA.; Present address: Novavax Vaccines, Washington, DC, USA.
Smyth D; The Moncton Hospital, Moncton, NB, Canada.
Trottier S; Centre Hospitalier Universitaire de Québec, QC, Canada.
Valiquette L; Université de Sherbrooke, Sherbrooke, QC, Canada.
Webster D; Horizon Health, Saint John, NB, Canada.
Ye L; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada.
McNeil SA; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Pokaż więcej
Źródło :
Journal of medical microbiology [J Med Microbiol] 2020 Feb; Vol. 69 (2), pp. 256-264. Date of Electronic Publication: 2019 Jun 28.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Influenza A virus/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*virology
Molecular Diagnostic Techniques/*methods
Multiplex Polymerase Chain Reaction/*methods
Adult ; Canada/epidemiology ; Female ; Hospitalization ; Humans ; Influenza A virus/classification ; Influenza A virus/genetics ; Influenza B virus/classification ; Influenza B virus/genetics ; Influenza, Human/diagnosis ; Influenza, Human/epidemiology ; Influenza, Human/therapy ; Male ; Middle Aged ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
[Establishment of RIG-I knockout 293T cell line and its effect on the replication of influenza B virus].
Autorzy :
Tain L; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Jiao P; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.; College of Animal Science and Technology, Guangxi University, Nanning 530004, Guangxi, China.
Hou L; China Institute of Veterinary Drug Control, Beijing 100081, China.
Li Y; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Song Z; The High School Affiliated to Beijing Normal University, Beijing 100052, China.
Liu W; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Fan W; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Sun L; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Pokaż więcej
Źródło :
Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Sheng Wu Gong Cheng Xue Bao] 2020 Jan 25; Vol. 36 (1), pp. 109-121.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza B virus*
DEAD Box Protein 58 ; HEK293 Cells ; Humans ; Immunity, Innate ; Interferons ; Virus Replication
Czasopismo naukowe
Tytuł :
Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
Autorzy :
Virk RK; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Jayakumar J; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Mendenhall IH; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Moorthy M; Department of Clinical Virology, Christian Medical College, Vellore, India 632004.
Lam P; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Linster M; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Lim J; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857.
Lin C; National Public Health Laboratory, Ministry of Health, Singapore 308442.
Oon LLE; Department of Molecular Pathology, Singapore General Hospital, Singapore 169608.
Lee HK; Department of Laboratory Medicine, National University Hospital, Singapore 117597.
Koay ESC; Department of Laboratory Medicine, National University Hospital, Singapore 117597.
Vijaykrishna D; Department of Microbiology, Biomedicine Discovery Institute, Monash University, VIC 3800, Australia.; World Health Organization Collaborating Centre in Influenza Research and Surveillance, Peter Doherty Institute, VIC 3000, Australia.
Smith GJD; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857; .; SingHealth Duke-NUS Global Health Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 169857.; Duke Global Health Institute, Duke University, Durham, NC 27710.
Su YCF; Programme in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Medical School, Singapore 169857; .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Jan 07; Vol. 117 (1), pp. 619-628. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Evolution, Molecular*
Communicable Diseases, Emerging/*virology
Epidemics/*prevention & control
Influenza B virus/*genetics
Influenza Vaccines/*therapeutic use
Influenza, Human/*virology
Communicable Diseases, Emerging/epidemiology ; Communicable Diseases, Emerging/immunology ; Communicable Diseases, Emerging/prevention & control ; Genetic Variation ; Genome, Viral/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Humans ; Influenza B virus/immunology ; Influenza B virus/pathogenicity ; Influenza, Human/epidemiology ; Influenza, Human/immunology ; Influenza, Human/prevention & control ; Neuraminidase/genetics ; Neuraminidase/immunology ; Selection, Genetic/immunology
Czasopismo naukowe
Tytuł :
Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.
Autorzy :
Nile SH; Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Kim DH; Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea.
Nile A; Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea.
Park GS; Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea.
Gansukh E; Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea; Department of Life Science and Biotechnology, Huree University, Ulaanbaatar, Mongolia. Electronic address: .
Kai G; Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China. Electronic address: .
Pokaż więcej
Źródło :
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2020 Jan; Vol. 135, pp. 110985. Date of Electronic Publication: 2019 Nov 22.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*pharmacology
Dianthus/*chemistry
Influenza A virus/*drug effects
Influenza B virus/*drug effects
Influenza, Human/*drug therapy
Quercetin/*analogs & derivatives
Animals ; Antiviral Agents/toxicity ; Cell Survival/drug effects ; Computer Simulation ; Dogs ; Humans ; In Vitro Techniques ; Influenza A virus/genetics ; Influenza A virus/physiology ; Influenza B virus/genetics ; Influenza B virus/physiology ; Influenza, Human/virology ; Madin Darby Canine Kidney Cells ; Molecular Docking Simulation ; Quercetin/pharmacology ; Quercetin/toxicity ; RNA, Viral/biosynthesis ; Reactive Oxygen Species/metabolism ; Virus Replication/drug effects
Czasopismo naukowe
Tytuł :
Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Autorzy :
Park JG; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Ávila-Pérez G; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Nogales A; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Animal Health Research, INIA-CISA, Valdeolmos, Madrid, Spain.
Blanco-Lobo P; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
de la Torre JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.
Martínez-Sobrido L; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Mar 17; Vol. 94 (7). Date of Electronic Publication: 2020 Mar 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antiviral Agents/*pharmacology
Influenza A Virus, H1N1 Subtype/*drug effects
Influenza A Virus, H3N2 Subtype/*drug effects
Influenza B virus/*drug effects
A549 Cells ; Animals ; Cell Proliferation ; Dogs ; Drug Evaluation, Preclinical ; Genome, Viral ; HEK293 Cells ; Host-Pathogen Interactions ; Humans ; Influenza A Virus, H1N1 Subtype/radiation effects ; Influenza A Virus, H3N2 Subtype/physiology ; Influenza B virus/physiology ; Madin Darby Canine Kidney Cells ; Virus Replication/drug effects
Czasopismo naukowe
Tytuł :
Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
Autorzy :
Rose A; Authors contributed equally to the study and manuscript writing.; Epiconcept, Paris, France.
Kissling E; Authors contributed equally to the study and manuscript writing.; Epiconcept, Paris, France.
Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Larrauri A; National Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
McMenamin J; Health Protection Scotland, Glasgow, United Kingdom.
Pozo F; National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Trebbien R; Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark.
Mazagatos C; National Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Whitaker H; Public Health England, London, United Kingdom.
Valenciano M; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors :
European IVE group; European Influenza Vaccine Effectiveness (IVE) group members are listed at the end of the article.
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2020 Mar; Vol. 25 (10).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*immunology
Influenza A Virus, H3N2 Subtype/*immunology
Influenza B virus/*immunology
Influenza Vaccines/*immunology
Vaccination/*statistics & numerical data
Adolescent ; Aged ; Case-Control Studies ; Child ; Child, Preschool ; Europe/epidemiology ; Female ; Humans ; Immunization ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Influenza B virus/isolation & purification ; Influenza Vaccines/administration & dosage ; Influenza, Human/prevention & control ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Seasons ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Clinical impact of rapid diagnostics using Xpert Flu/RSV™ PCR on antimicrobial stewardship initiatives during influenza season.
Autorzy :
Chavada R; NSW Health Pathology-Central Coast, Gosford, Australia. Electronic address: .
Clifford L; Department of Medicine, Gosford/Wyong Hospital, Gosford, NSW, 2250, Australia.
Weisback O; Department of Medicine, Gosford/Wyong Hospital, Gosford, NSW, 2250, Australia.
Pokaż więcej
Źródło :
Infection, disease & health [Infect Dis Health] 2020 Mar; Vol. 25 (2), pp. 71-76. Date of Electronic Publication: 2019 Dec 06.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Influenza A virus*/genetics
Influenza B virus*/genetics
Point-of-Care Testing*
Influenza, Human/*diagnosis
Aged ; Antimicrobial Stewardship ; Female ; Humans ; Male ; Middle Aged ; Nasopharynx ; Real-Time Polymerase Chain Reaction ; Regression Analysis ; Seasons ; Specimen Handling
Czasopismo naukowe
Tytuł :
Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010-2018.
Autorzy :
Chen Y; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Leng K; Department of Occupational and Environmental Health, School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang110122, P.R. China.
Lu Y; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Wen L; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Qi Y; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Gao W; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Chen H; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Bai L; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
An X; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Sun B; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Wang P; Department of Infectious Disease, Shenyang center for Disease Control and Prevention, Shenyang110031, Liaoning Province, PR China.
Dong J; Department of Occupational and Environmental Health, School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang110122, P.R. China.
Pokaż więcej
Źródło :
Epidemiology and infection [Epidemiol Infect] 2020 Feb 14; Vol. 148, pp. e29. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Journal Article
MeSH Terms :
Epidemiological Monitoring*
Influenza A virus/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Influenza, Human/*virology
Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; China/epidemiology ; Female ; Geography ; Hospitals ; Humans ; Incidence ; Infant ; Infant, Newborn ; Influenza A virus/classification ; Influenza B virus/classification ; Male ; Middle Aged ; Rural Population ; Seasons ; Urban Population ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies